Ku Shen

Sophora flavescens Ait.

Also known as: Flavescent Sophora Root(English) 苦参(Chinese)

Kujin苦参 クジン Gosam苦參 고삼 K'u Shên

Updated October 5, 2026 · Not yet clinically reviewed

Ku Shen
Photo: Dalgial, CC BY-SA 3.0, via Wikimedia Commons

Safety at a glance

High risk

Do not combine with Li Lu (十八反)

Caution

7 recorded drug interactions, 5 major or contraindicated

Note

Contraindications or side effects are listed

No rule in our tables for this herb: pregnancy, breastfeeding, herb–drug, dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Traditional Chinese Medicine

Category
clearing heat
Temperature
Cold
Taste
Bitter
Channels
Heart,Liver,Stomach,Large Intestine

Functions

Clears Heat and dries Dampness; Kills Parasites and Stops Itching; Promotes Urination; Disperses Wind

Traditional uses

Ku Shen (苦参) is the root of Sophora flavescens Ait. (Fabaceae), Radix Sophorae Flavescentis. It is profoundly bitter and cold, entering the Heart, Liver, Stomach, Large Intestine and Bladder channels. It clears Heat and dries Dampness, kills parasites and stops itching, promotes urination, and disperses Wind.

Internally it treats Damp-Heat in the lower body: dysenteric disorders with blood and pus, jaundice, scanty painful urination, and Damp-Heat vaginal discharge. Its best-known use is external and dermatological — decocted as a wash or soak for eczema, weeping and itching skin lesions, scabies, tinea, genital itching and trichomonal infestation, where its parasiticidal and anti-pruritic actions are combined with its drying of Dampness.

It is one of the harshest cold, drying herbs in routine use and readily damages Stomach Qi; it is contraindicated where the Spleen and Stomach are deficient and cold, and is classically held to counteract Li Lu (Veratrum).

Western herbalism

Properties: bitter, alterative, anti-inflammatory, antimicrobial, diuretic

Pharmacological effects

  • Antiarrhythmic: Root injection, total alkaloids (200 mg/kg i.v.), total flavones, matrine, oxymatrine and sophocarpine antagonized chemically induced arrhythmias in mice, rats, guinea pigs, rabbits, cats and dogs; flavones also in cultured rat myocardial cells.
  • Other cardiovascular: Injection caused bradycardia, reduced contractility and prolonged P-R interval, increased coronary flow, lowered blood pressure and dilated ear and renal vessels in animals; vexibinol and kurarinone inhibited aortic contraction, suggesting Ca2+ channel blockade.
  • Antiasthmatic, antitussive, expectorant: Fluid extract, decoction and alkaloids protected guinea pigs from histamine asthma (comparable to aminophylline); oral oxymatrine acts via conversion to matrine; sophocarpine antitussive; total flavones expectorant in mice.
  • Antibacterial, antiinflammatory, antipyretic: Matrine inhibited Shigella, E. coli, Proteus, streptococci and S. aureus in vitro, reduced paw and ear inflammation in rats and was antipyretic in yeast-fevered rats.
  • Leukopenia prophylaxis: Total alkaloids and oxymatrine (not matrine) were therapeutic in X-ray-induced leukopenia in rabbits.
  • Antiulcerative: Oxymatrine and matrine reduced stress and other ulcers in rats; vexibinol 25-50 mg/kg oral inhibited ulcers and acid secretion.
  • Antineoplastic and immunological: Matrine and oxymatrine active against sarcoma 180; sophocarpine inhibited several transplanted tumours and tumour DNA synthesis; matrine immunosuppressive in vitro.
  • Other effects: Oxymatrine 3.6 mg/kg i.m. reduced CCl4 or galactosamine liver injury; diuretic effects reported but questionable.

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 149.

Formulas using this herb

13 of 13 formulas

Botanical

Sophora flavescens (Ku Shen, shrubby sophora) is a perennial subshrub or herbaceous perennial in the Fabaceae family, growing 50 to 150 centimeters tall from a long, cylindrical, yellowish woody taproot that constitutes the medicinal material. The erect, ridged, sparsely branched stems bear alternate, odd-pinnate leaves 20 to 25 centimeters long with 11 to 25 ovate to oblong-lanceolate leaflets 3 to 4 centimeters long, finely pubescent on the lower surface. From mid summer to early autumn, dense terminal racemes 15 to 25 centimeters long bear numerous pale yellow to cream papilionaceous flowers about 1.5 centimeters long, characteristic of the legume family. The legume pods are linear-cylindrical, 5 to 10 centimeters long, slightly constricted between the seeds, with a long beak. The bark of the root is yellowish-brown, the wood pale yellow and intensely bitter when chewed, giving rise to the Chinese name Ku Shen (bitter root). Native to East Asia, widely distributed across China, Korea, Japan, and Russia.

Family
Fabaceae
Pharmaceutical name
Radix Sophorae Flavescentis
Parts used
root
Plant type
shrub
Native region
Hebei, Henan, Hubei, Shanxi

Constituents

Matrine

Quinolizidine (matrine-type) alkaloid

The principal alkaloid of the root and, with oxymatrine, the Chinese Pharmacopoeia assay marker: the two together must total at least 1.2 percent of the dried root. Matrine has anti-inflammatory, antiviral, antifibrotic, antiparasitic and sedative activity in preclinical work, but its serious adverse effects, chiefly hepatotoxicity and neurotoxicity, are the main factors limiting clinical use. Matrine cardiotoxicity has been traced experimentally to depletion of cysteine and glutathione with mitochondrial dysfunction and caspase-mediated apoptosis.

Oxymatrine

Quinolizidine alkaloid N-oxide

The N-oxide of matrine and the other Pharmacopoeia assay marker. It is largely reduced to matrine in vivo, so oxymatrine exposure carries matrine toxicity. Isolated oral oxymatrine, not Ku Shen decoction, is the form used in the chronic hepatitis B trial literature.

Sophoridine

Quinolizidine (matrine-type) alkaloid

A matrine stereoisomer present in the root and quantified alongside matrine and oxymatrine in HPLC assays of Kushen. It has been reported to cause hepatotoxicity, neurotoxicity and cytotoxicity in cell and animal studies.

Sophocarpine

Quinolizidine (matrine-type) alkaloid

An unsaturated matrine analogue. In zebrafish embryos, sophocarpine and matrine altered spontaneous movement and impaired swimming at concentrations below those causing lethality or malformation, which is direct evidence of neurotoxic potential at sublethal exposure.

Kurarinone

Prenylated flavanone

A major prenylated flavonoid of Sophora flavescens and the constituent identified as the main hepatotoxic principle: it accumulates in rat liver and drives the hepatotoxicity of the extract. This is important because Ku Shen hepatotoxicity is often attributed to the alkaloids alone; the flavonoid fraction matters too, and alkaloid-standardised quality control does not control for it.

Kushenol series (kushenol A, I and congeners)

Prenylated flavonoid

A large series of prenylated flavonoids characteristic of this species, linked in preclinical work to antimicrobial, antioxidant and antitumour activity. They are not covered by the Pharmacopoeia assay, so their content varies widely between batches.

Trifolirhizin

Pterocarpan glycoside

A pterocarpan glycoside of the root reported to contribute to the antimicrobial and anti-inflammatory activity of Kushen extracts. Evidence is in vitro.

Drug interactions

Theophylline and other CYP1A2 substrates (e.g. clozapine, tizanidine)

Major · Accelerated clearance and loss of effect of a narrow-therapeutic-index drug · Evidence level: Possible

A rat study of whole Sophora flavescens extract found induction of hepatic cytochrome P450s with a measurable impact on theophylline elimination. Because theophylline has a narrow therapeutic index and its toxicity is dose-related in both directions, an unquantified induction effect is clinically significant. The evidence is animal, in this species, with the whole extract rather than isolated alkaloids.

Clinical note: Avoid concurrent use. If a patient on theophylline has already been taking Ku Shen, check a theophylline level before and after stopping the herb, since clearance may fall again on withdrawal.

Indinavir and other CYP3A4 or P-glycoprotein substrate antiretrovirals

Major · Reduced antiretroviral exposure, with risk of virological failure and resistance · Evidence level: Possible

In rats, Sophora flavescens reduced the oral exposure of indinavir, with the authors attributing the effect to CYP3A and P-glycoprotein. Oxymatrine contributed at least partly to the CYP induction, and Sophora flavescens induced CYP3A expression through activation of the pregnane X receptor. For protease inhibitors, even a modest fall in trough concentration can select resistance.

Clinical note: Do not combine Ku Shen with protease inhibitors or other antiretrovirals without specialist input. Ask HIV-positive patients directly about herbal use rather than waiting for them to volunteer it.

CYP2B6 substrates (efavirenz, bupropion, cyclophosphamide, methadone)

Moderate · Altered drug exposure through enzyme induction; for cyclophosphamide, altered activation to its cytotoxic metabolite · Evidence level: Possible

Matrine and oxymatrine dose-dependently induced the activity and gene expression of CYP2B1, the rat orthologue of human CYP2B6, with the effect attributed to constitutive androstane receptor activation. Matrine also slightly induced CYP2E1. These are rat data with isolated alkaloids, so the human magnitude is unknown.

Clinical note: Flag for any patient on a CYP2B6-dependent drug, particularly methadone, where induction can precipitate withdrawal.

Hepatotoxic drugs (paracetamol, methotrexate, isoniazid, azoles, statins)

Major · Additive hepatocellular injury; transaminase rise, jaundice · Evidence level: Probable

Ku Shen hepatotoxicity is documented experimentally and mechanistically: kurarinone accumulates in rat liver and is identified as a major hepatotoxic constituent of the extract, and matrine and sophoridine are separately reported to cause hepatotoxicity. Matrine cardiotoxicity works partly through depletion of cysteine and glutathione via the ATF4/CTH pathway, and glutathione depletion is exactly the mechanism by which paracetamol injures the liver, so the two insults converge.

Clinical note: Do not use Ku Shen in a patient with existing liver disease or on other hepatotoxic drugs. Check liver function before starting prolonged courses and again at four to six weeks, and stop at the first unexplained transaminase rise.

Antiarrhythmics, beta-blockers and non-dihydropyridine calcium channel blockers (verapamil, diltiazem)

Moderate · Additive bradycardia, hypotension and palpitation · Evidence level: Possible

Acute Sophora alkaloid poisoning in Hong Kong, most often attributed to excessive doses of Sophora flavescens, presents with dizziness, vomiting and palpitation. Matrine cardiotoxicity has been demonstrated experimentally through reactive oxygen species accumulation, mitochondrial permeability transition pore opening, loss of mitochondrial membrane potential and caspase-9 and caspase-3 activation. Adding cardiodepressant drugs to a cardiotoxic alkaloid load has no supporting study but an obvious rationale.

Clinical note: Avoid in patients with conduction disease or on rate-limiting cardiac drugs, and keep strictly to Pharmacopoeia dosing. Palpitation or dizziness in a patient taking Ku Shen should be treated as possible alkaloid toxicity, not dismissed.

Veratrum nigrum (Li Lu)

Major · Classical prohibition; Veratrum alkaloids are themselves cardiotoxic and emetic · Evidence level: Theoretical

Ku Shen is one of the shen-named herbs prohibited with Li Lu under the classical Eighteen Incompatibilities. No pharmacokinetic study supports the pairing being uniquely dangerous, but the underlying hazard is real independent of the classical rule: Veratrum steroidal alkaloids cause bradycardia, hypotension and violent vomiting, and combining them with a matrine-type alkaloid that is itself cardiotoxic and emetic stacks the same toxicity.

Clinical note: Observe the classical prohibition. Veratrum should not be in a modern prescription at all in most jurisdictions.

Substitution or confusion with Shan Dou Gen (Sophora tonkinensis) and Ku Dou Zi (Sophora alopecuroides)

Major · Unintended matrine-type alkaloid overdose · Evidence level: Possible

All three drugs carry matrine, oxymatrine, sophocarpine and sophoridine, and acute Sophora alkaloid poisoning in Chinese medicine practice is commonly the result of an excessive alkaloid dose. Sophora tonkinensis root in particular is the Sophora most associated with alkaloid poisoning and has a considerably narrower margin than Kushen, so a mis-supplied or co-prescribed Sophora silently multiplies the alkaloid load on the prescription.

Clinical note: Check the botanical identity on the supplier certificate, not just the pinyin name, and add up the total matrine-type alkaloid burden across the whole formula rather than reviewing each herb independently.

Dosage

FormAmountFrequencyNotes
decoction4.5–9 gDaily
中国药典 2020 【用法与用量】4.5~9g。外用适量,煎汤洗患处。 【注意】不宜与藜芦同用。 【性味与归经】苦,寒。归心、肝、胃、大肠、膀胱经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value.

Evidence

Study design on record, not certainty of outcome.

Systematic review / meta-analysis
1
Observational / case report
1
In vitro / animal
4

Oral oxymatrine preparation for chronic hepatitis B: A systematic review of randomized controlled trials

Wei-jiang Song, Jing Luo, Tong Wu, Shu-kun Yao · Chinese Journal of Integrative Medicine · 2015 · systematic review

Systematic review / meta-analysis · Verified

Fifty-two randomised trials in 5227 participants of oral oxymatrine capsules or tablets in chronic hepatitis B, of which 51 entered meta-analysis. Oral oxymatrine was associated with statistically significant effects on clearance of HBV DNA, HBsAg and HBeAg. The important caveat for a Ku Shen monograph is that this is isolated oxymatrine, mostly in trials of uncertain methodological quality, and it is not evidence for a Sophora flavescens decoction.

doi:10.1007/s11655-015-2143-0

Acute Sophora alkaloid poisoning in Hong Kong

Tsz Kit Chow, Rex Pui Kin Lam, Chi Keung Chan, Man Li Tse, Yibin Feng, Timothy Hudson Rainer · Toxicon · 2025 · cohort

Observational / case report · Not yet verified

A review of confirmed acute Sophora alkaloid poisonings, in which the cases were most often caused by an excessive dose of Sophora flavescens. Symptoms were described as generally mild and included dizziness, vomiting and palpitation. This is the best available human evidence for the toxicity of this specific species as used in Chinese medicine.

doi:10.1016/j.toxicon.2025.108251

Hepatotoxicity Induced by Sophora flavescens and Hepatic Accumulation of Kurarinone, a Major Hepatotoxic Constituent of Sophora flavescens in Rats

Peng Jiang, Xiuwen Zhang, Yutong Huang, Nengneng Cheng, Yueming Ma · Molecules · 2017 · animal

In vitro / animal · Not yet verified

Rats given Sophora flavescens extract developed liver injury, and the prenylated flavanone kurarinone accumulated in liver tissue and was identified as a major hepatotoxic constituent. This locates a substantial part of Ku Shen hepatotoxicity in the flavonoid fraction rather than the alkaloids, which the Pharmacopoeia assay does not measure.

doi:10.3390/molecules22111809

Induction of Hepatic Cytochrome P450s by the Herbal Medicine Sophora flavescens Extract in Rats: Impact on the Elimination of Theophylline

Yune-Fang Ueng, Ching-Chin Tsai, Wei-Sheng Lo, Chul-Ho Yun · Drug Metabolism and Pharmacokinetics · 2010 · animal

In vitro / animal · Verified

Sophora flavescens extract induced hepatic cytochrome P450 enzymes in rats and altered theophylline elimination. This is the primary experimental basis for treating Ku Shen as an enzyme inducer rather than assuming it is pharmacokinetically inert.

doi:10.2133/dmpk.dmpk-10-rg-055

Impact of the Herbal Medicine Sophora flavescens on the Oral Pharmacokinetics of Indinavir in Rats: The Involvement of CYP3A and P-Glycoprotein

Jia-Ming Yang, Siu-Po Ip, Yanfang Xian, Ming Zhao, Zhi-Xiu Lin, John Hok Keung Yeung, Raphael Chiu Yeung Chan, Shui-Shan Lee, Chun-Tao Che · PLoS ONE · 2012 · animal

In vitro / animal · Verified

Sophora flavescens altered the oral pharmacokinetics of the protease inhibitor indinavir in rats, with the authors implicating induction of CYP3A and P-glycoprotein. It is the most directly relevant experiment for the antiretroviral interaction warning.

doi:10.1371/journal.pone.0031312

Effects of Matrine and Oxymatrine on Catalytic Activity of Cytochrome P450s in Rats

Fang Yuan, Jie Chen, Wen-jin Wu, Su-zhen Chen, Xue-ding Wang, Zeng Su, Min Huang · Basic & Clinical Pharmacology & Toxicology · 2010 · animal

In vitro / animal · Verified

Matrine and oxymatrine given to rats for 14 days dose-dependently induced CYP2B1 activity and gene expression, with matrine also slightly inducing CYP2E1. This identifies which enzymes the isolated alkaloids affect, as distinct from the whole-extract studies, and underpins the CYP2B6 substrate warning.

doi:10.1111/j.1742-7843.2010.00596.x

Safety

Contraindications

Its use is prohibited in patients with deficiency-cold of the spleen and stomach. It antagonizes Radix et Rhizoma Veratri Nigri ( li lu ).

Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 46–50.

Side effects

  • Occasional mild dizziness, nausea, vomiting and constipation, usually resolving spontaneously.

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 149.

⚠ Rule-based cautions

These entries come from the deterministic rule tables that gate Verscienta's formula tools: classical pair prohibitions, pregnancy and lactation contraindications, dose ceilings, and drugs outside the Chinese Pharmacopoeia. The botanical-genus entries are different: advisory notes are not part of the safety screen; the Aristolochia genus check is.

Incompatibilities (十八反 / 十九畏)

  • 十八反: Li Lu × Ku Shen — avoid combining with Li Lu / Veratrum

Cultural and historical

Shen Nong Ben Cao Jing · Han dynasty

Ku Shen is recorded here as a middle-grade (zhong pin) drug, the earliest documentation of the root's medicinal use. The classical indications centre on clearing heat, draining damp, killing parasites and promoting urination, and it is applied to dysentery, jaundice and skin disease.

Ben Cao Gang Mu (Compendium of Materia Medica), Li Shizhen · Ming dynasty, 1596

Describes the root as bitter in taste and cold in nature, clearing heat, dispelling wind, relieving damp painful obstruction and brightening the eyes. Li Shizhen also explains the name: ku for its taste, shen for its function as a root remedy, and the alternative huai from the resemblance of its leaves to those of the scholar tree.

References

  1. Xirui He, Jiacheng Fang, Linhong Huang, Jinhui Wang, Xiaoqiang Huang. Sophora flavescens Ait.: Traditional usage, phytochemistry and pharmacology of an important traditional Chinese medicine. Journal of Ethnopharmacology. 2015 doi:10.1016/j.jep.2015.06.010
  2. Longtai You, Chunjing Yang, Yuanyuan Du, Wenping Wang, Mingyi Sun, Jing Liu, Baorui Ma, Linnuo Pang, Yawen Zeng, Zhiqin Zhang, Xiaoxv Dong, Xingbin Yin, Jian Ni. A Systematic Review of the Pharmacology, Toxicology and Pharmacokinetics of Matrine. Frontiers in Pharmacology. 2020 doi:10.3389/fphar.2020.01067
  3. Xia Li, Ziwei Tang, Li Wen, Cen Jiang, Quansheng Feng. Matrine: A review of its pharmacology, pharmacokinetics, toxicity, clinical application and preparation researches. Journal of Ethnopharmacology. 2021 doi:10.1016/j.jep.2020.113682

Look-alike names

© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice